Skip to main content

Table 2 Patient descriptions

From: Selection process for botulinum toxin injections in patients with chronic-stage hemiplegic stroke: a qualitative study

ID

Age

MMSE or HDS-R score

Onset (years prior to the study)

Functional autonomy

How did the patient learn about BT and make a decision?

A

45–49

MMSE = 24

5

Could go out with a cane and a lower extremity orthosis.

BT was introduced by the primary physician.

Patient selected BT injection to enhance gait stability and improve upper limb activity.

B

55–59

MMSE = 29

10

Could go out with a cane and a lower extremity orthosis.

BT was introduced by the primary physician.

Patient selected BT injection to enhance gait stability and improve upper limb activity.

C

60–64

HDS-R = 26

4

Could go out.

BT recommended for a tingling sensation in the foot.

Patient did not select BT injection owing to the possibility of convulsions.

D

60–64

MMSE = 28

8

Could go out with a cane and a lower extremity orthosis under supervision.

Patient was looking for better treatment options and obtained information about BT.

Selected BT injection to enhance gait stability and improve upper limb activity.

E

60–64

HDS-R = 26

9

Could go out with a cane and a lower extremity orthosis.

Patient heard about BT from patients who had received BT and healthcare professionals. Selected BT injection to enhance gait stability.

F

70–74

MMSE = 26

6

Could go out with a cane and a lower extremity orthosis under supervision.

BT recommended by healthcare professionals and family members.

Selected BT injection to enhance gait stability and improve upper limb activity.

  1. BT Botulinum toxin, MMSE Mini-Mental State Examination, HDS-R Revised Hasegawa’s Dementia Scale